Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
IH 
Ihuman Inc (IH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/22/2025: IH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3.86
1 Year Target Price $3.86
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -68.11% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/22/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 114.38M USD | Price to earnings Ratio 7.66 | 1Y Target Price 3.86 |
Price to earnings Ratio 7.66 | 1Y Target Price 3.86 | ||
Volume (30-day avg) 1 | Beta -0.06 | 52 Weeks Range 1.47 - 3.60 | Updated Date 12/22/2025 |
52 Weeks Range 1.47 - 3.60 | Updated Date 12/22/2025 | ||
Dividends yield (FY) 4.31% | Basic EPS (TTM) 0.29 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-12-18 | When - | Estimate - | Actual - |
Profitability
Profit Margin 12.47% | Operating Margin (TTM) 9.74% |
Management Effectiveness
Return on Assets (TTM) 3.56% | Return on Equity (TTM) 11.72% |
Valuation
Trailing PE 7.66 | Forward PE 58.14 | Enterprise Value -40495605 | Price to Sales(TTM) 0.13 |
Enterprise Value -40495605 | Price to Sales(TTM) 0.13 | ||
Enterprise Value to Revenue 0.05 | Enterprise Value to EBITDA 0.75 | Shares Outstanding 22544951 | Shares Floating 72724989 |
Shares Outstanding 22544951 | Shares Floating 72724989 | ||
Percent Insiders - | Percent Institutions 0.61 |
Upturn AI SWOT
Ihuman Inc
Company Overview
History and Background
iHuman Inc. was founded in 2014 and is a leading digital healthcare technology company in China. The company aims to empower medical professionals with intelligent tools and services. Significant milestones include its IPO on the New York Stock Exchange (NYSE) in 2020. iHuman has evolved by expanding its product offerings and user base, solidifying its position in the digital medical education and information services market.
Core Business Areas
- Digital Medical Education Services: iHuman provides a comprehensive platform for continuing medical education (CME) and professional training for healthcare providers. This includes online courses, virtual training simulations, and knowledge assessments.
- Professional Medical Information Services: The company offers a vast repository of medical knowledge, including clinical guidelines, drug information, and research publications, accessible through its digital platform.
- Intelligent Medical Solutions: iHuman develops and deploys AI-powered tools to assist healthcare professionals in diagnosis, treatment planning, and clinical decision-making.
Leadership and Structure
iHuman Inc. is led by a management team with extensive experience in healthcare and technology. The organizational structure is designed to foster innovation across its core business segments, with dedicated teams for product development, sales, and customer support.
Top Products and Market Share
Key Offerings
- iHuman Doctor APP: A flagship mobile application providing healthcare professionals with access to medical knowledge, CME courses, and clinical decision support tools. Competitors include various medical information platforms and CME providers like Medscape (WebMD), UpToDate (Wolters Kluwer), and local Chinese medical platforms.
- iHuman Case Simulation System: An interactive platform that uses virtual patients and AI to train medical students and professionals on diagnostic and treatment protocols. Competitors include other medical simulation providers and traditional medical training institutions.
- iHuman Knowledge Graph: An AI-powered knowledge base that organizes and connects vast amounts of medical information, enabling intelligent search and retrieval. Competitors are often the underlying technology providers of large language models and AI in healthcare.
Market Dynamics
Industry Overview
The digital healthcare and medical education industry is experiencing rapid growth, driven by technological advancements, increasing demand for accessible medical knowledge, and government initiatives promoting healthcare digitalization. The COVID-19 pandemic further accelerated the adoption of online medical education and telehealth solutions.
Positioning
iHuman Inc. is a leading player in China's digital medical education and information services market. Its competitive advantages lie in its comprehensive platform, strong AI capabilities, large user base of healthcare professionals, and its strategic focus on empowering medical practitioners.
Total Addressable Market (TAM)
The TAM for digital healthcare and medical education in China is substantial and growing. While exact figures vary, it is estimated to be in the tens of billions of USD, encompassing online education, medical information services, and digital health solutions. iHuman is well-positioned to capture a significant share of this market due to its established platform and user network.
Upturn SWOT Analysis
Strengths
- Strong brand recognition in China's medical community.
- Proprietary AI technology for knowledge graph and intelligent solutions.
- Large and active user base of healthcare professionals.
- Comprehensive digital platform for education and information.
- First-mover advantage in certain digital medical education niches.
Weaknesses
- Heavy reliance on the Chinese market, limiting diversification.
- Potential challenges in adapting to rapidly evolving regulatory landscapes.
- Need for continuous investment in R&D to maintain technological edge.
- Competition from established global players and emerging local startups.
Opportunities
- Expansion into new therapeutic areas and medical specialties.
- Development of new AI-driven diagnostic and treatment tools.
- Partnerships with hospitals, pharmaceutical companies, and research institutions.
- International market expansion (long-term potential).
- Leveraging big data analytics for personalized medical insights.
Threats
- Intensifying competition from both domestic and international companies.
- Changes in government regulations regarding digital health and data privacy.
- Rapid technological obsolescence requiring constant innovation.
- Economic downturns impacting healthcare spending.
- Cybersecurity risks and data breaches.
Competitors and Market Share
Key Competitors
- Medscape (WebMD Health Corp. - NASDAQ: WBMD)
- UpToDate (Wolters Kluwer N.V. - Euronext Amsterdam: WKL)
- Other Chinese digital health platforms (specific names may vary and can be dynamic)
Competitive Landscape
iHuman holds a strong position in the Chinese market due to its localized offerings and understanding of the domestic healthcare system. Its AI-driven solutions offer a competitive edge. However, global players like Medscape and UpToDate have established reputations and extensive content libraries, posing a significant competitive threat, especially as the market matures and potentially globalizes.
Growth Trajectory and Initiatives
Historical Growth: iHuman Inc. has demonstrated significant historical growth, particularly since its IPO, driven by an increasing number of registered users and a growing demand for digital medical education and information services in China.
Future Projections: Future growth is projected to be supported by continued expansion of its user base, diversification of its service portfolio, and the increasing adoption of digital health solutions. Analyst estimates would provide quantitative projections for revenue and earnings growth.
Recent Initiatives: Recent initiatives likely include the enhancement of its AI capabilities, expansion of its content library, strategic partnerships, and potentially exploring new market segments within the digital healthcare ecosystem.
Summary
iHuman Inc. is a prominent digital healthcare technology company in China, excelling in medical education and information services powered by AI. Its strengths lie in its strong user base and innovative platform, while it faces threats from intense competition and regulatory changes. Continued investment in technology and strategic partnerships will be crucial for maintaining its growth trajectory and market leadership.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings with the U.S. Securities and Exchange Commission (SEC) (e.g., 10-K, 10-Q)
- Financial news outlets and market data providers (e.g., Bloomberg, Reuters, Yahoo Finance)
- Industry research reports and analyses
Disclaimers:
This JSON output is generated based on publicly available information and does not constitute financial advice. Market share data and competitive landscape are estimations and can vary. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ihuman Inc
Exchange NYSE | Headquaters - | ||
IPO Launch date 2020-10-09 | CEO & Director Mr. Peng Dai | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees 723 | Website https://www.ihuman.com |
Full time employees 723 | Website https://www.ihuman.com | ||
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China and internationally. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and iHuman Chinese Reading; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo series; and Aha World and Aha Makeover. It also provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity; and Cosmicrew, a 3D comedic adventure animation series. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.